Results 101 to 110 of about 43,946 (263)

Analytical Approaches to Address Challenges in the Analysis of Cannabinoids in Vascular Matrices Using Mass Spectrometry

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Phytocannabinoids are bioactive metabolites derived from the Cannabis sativa plant. They have garnered attention due to their recreational uses and therapeutic potential. Although various analytical strategies have been employed for their analysis, mass spectrometry (MS) coupled to chromatographic separation is superior due to its sensitivity ...
Radwa Mahmoud, Robert B. Laprairie, Anas El‐Aneed   +2 more
wiley   +1 more source

Cannabinoids in neurology – Brazilian Academy of Neurology

Arquivos de Neuro-Psiquiatria, 2015
The use of cannabidiol in some neurological conditions was allowed by Conselho Regional de Medicina de São Paulo and by Agência Nacional de Vigilância Sanitária (ANVISA).
Sonia M. D. Brucki, Norberto Anísio Frota, Pedro Schestatsky, Adélia Henriques Souza, Valentina Nicole Carvalho, Maria Luiza Giraldes Manreza, Maria Fernanda Mendes, Elizabeth Comini-Frota, Cláudia Vasconcelos, Vitor Tumas, Henrique B. Ferraz, Egberto Barbosa, Mauro Eduardo Jurno   +12 more
doaj   +1 more source

The Medicalization of Cannabis [PDF]

, 2010
Annotated and edited transcript of a Witness Seminar held on 24 March 2009. Introduction by Professor Leslie Iversen.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2010.©The Trustee of the Wellcome Trust, London, 2010 ...
Crowther, SM, Reynolds, LA, Tansey, EM
core  

Additional file 1 of Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015

, 2022
Albert Stuart Reece, Gary Kenneth Hulse
openalex   +1 more source

Promoting Well‐Being Among Gastroenterologists – A Call for Systemic Action

United European Gastroenterology Journal, EarlyView.
ABSTRACT United European Gastroenterology (UEG) has launched an initiative to promote physician well‐being and prevent burnout. This current concept article is based on a survey of the National Societies Forum and National Societies Committee, a meta‐analysis by Shiha et al., and a scoping review of evidence‐based interventions.
Katharina Zimmermann, Iago Rodríguez‐Lago, Reena Sidhu, Henriette Heinrich, Paula Sousa, Egle Dieninyte, Marjolijn Duijvestein, Alexander Hann, Manik Gemilyan, Helge Knüttel, Andrea Nowak, Paolo Montalto, Mohamed G. Shiha, Petra Krčálová, Petr Vanek, Vita Skuja, Martin Duricek, Francesca Manza, John Ong, Dina Tiniakos, Neeraj Bhala, Martina Müller   +21 more
wiley   +1 more source

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. [PDF]

, 2007
A nonpsychoactive cannabinoid cannabidiol (CBD) has been shown to exert potent anti-inflammatory and antioxidant effects and has recently been reported to lower the incidence of diabetes in nonobese diabetic mice and to preserve the blood-retinal barrier
Bátkai, S., Drel, V.R., Haskó, G., Liaudet, L., Mukhopadhyay, P., Obrosova, I.G., Pacher, P., Rajesh, M.   +7 more
core   +1 more source

Effects of cannabidiol in alcohol use disorder patients with and without co‐occurring post‐traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof‐of‐concept trials

Alcohol, Clinical and Experimental Research, EarlyView.
Two small placebo‐controlled trials evaluated the effects of cannabidiol (CBD) in patients with alcohol use disorder (AUD), with and without co‐occurring post‐traumatic stress disorder (PTSD). CBD was rapidly absorbed and generally well tolerated in dosages of up to 1200 mg/day. Both treatment groups showed large reductions in drinking.
Michael P. Bogenschutz, Esther Blessing, Danielle Dgheim, Dayeon Cho, Jun Zhang, Eugene M. Laska, Charles R. Marmar   +6 more
wiley   +1 more source

∆9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol

Frontiers in Pharmacology, 2016
Animal studies and preliminary clinical trials have shown that cannabidiol-enriched extracts may have beneficial effects for children with treatment-resistant epilepsy.
José Alexandre Crippa, Ana Chrystina S Crippa, Jaime Eduardo Hallak, Rocio Martin-Santos, Antonio Waldo Zuardi   +4 more
doaj   +1 more source

Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression [PDF]

, 2012
Background: Endocannabinoids (ECs) are rapidly acting immune-modulatory lipid-signaling molecules that are important for adaptation to stressful and aversive situations. They are known to interact with glucocorticoids and other stress-responsive systems.
Beiras-Fernandez, Andres, Campolongo, Patrizia, Giehl, Markus, Hauer, Daniela, Kilger, Erich, Schelling, Gustav, Schopp, Mirjam, Strewe, Claudia, Toth, Roland, Weis, Florian   +9 more
core   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source